Immunological synapse (IS) (IS)

The immunological synapse (IS) is a specialized, highly organized interface formed between a T cell and an antigen-presenting cell (APC) or a target cell (Dustin, 2014, Cancer Immunology Research). It facilitates the concentrated exchange of signals required for T cell activation, effector function, and directed secretion of cytokines or lytic granules (Grakoui et al., 1999, Science). The synapse is characterized by the spatial rearrangement of receptors and ligands into supramolecular activation clusters (SMACs), including central (cSMAC), peripheral (pSMAC), and distal (dSMAC) regions (Huppa & Davis, 2003, Nature Reviews Immunology). Key molecules involved include the T-cell receptor (TCR) complex, costimulatory receptors like CD28, inhibitory receptors like PD-1, and adhesion molecules such as LFA-1 (UniProt, 2024). This interface is a critical site for therapeutic intervention, as many immunotherapies, including checkpoint inhibitors like pembrolizumab and CAR-T cells, function by modulating the signaling events occurring within this structure (PubMed, 2023). In the context of dendritic cell vaccines and cytotoxic T lymphocyte (CTL) activity, the stability and composition of the synapse determine the strength and duration of the immune response (Figdor et al., 2002, Nature Reviews Immunology). Consequently, the immunological synapse is a central focus in the study of cancer immunotherapy, autoimmunity, and infectious diseases (StatPearls, 2024).

Other names

Immune synapseSupramolecular activation clusterSMACT-cell synapseCostimulatory and adhesion molecule interface

Modulation of costimulatory and inhibitory signaling pathways and inhibition of cell-cell adhesion within the immunological synapse (StatPearls, 2024; Nature Reviews Immunology, 2002).